← SynDRA
CANRENOATE
SynDRA canonical compound SYN0025729 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | NR3C2 |
|---|
| Mechanism of action | Mineralocorticoid receptor antagonist |
|---|
| Indication | edema |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Mineralocorticoid receptor antagonist
- NR3C2 ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PGR
- PDE4D
- NR3C1
- ADORA1
- OPRK1
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR1I2
- OPRD1
- OPRM1
- HTR1A
- PDE3A
- PTGS2
- SAMHD1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B1
- SLCO1B3
- TBXA2R
- HTR2A
- HRH3
- ADORA2A
- HRH2
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Diuretics
- Hormone Antagonists
- Mineralocorticoid Receptor Antagonists
- Natriuretic Agents
ATC classes
- C03D · ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS
Cross-references
Synonyms
- potassium canrenoate
- aldadiene kalium
- aldadiene potassium
- canrenoate potassium
- kanrenol
- canrenoic acid
- canrenoic acid potassium
- canrenoic acid potassium salt
- Canrenoic acid
- Acide canrenoique
- Acido canrenoico
- potassium-canrenoate
- Canrenoic Acid
- Acidum canrenoicum
- CHEBI:50156
- Acid, Canrenoic
- Kalium Can. Ratiopharm
- RefChem:123245
- DTXCID602726
- Aladiene
- Canrenoic Acid [INN:BAN]
- UNII-87UG89VA9K
- Canrenoinsaure
- Acide canrenoique [INN-French]
- Acido canrenoico [INN-Spanish]
- Acidum canrenoicum [INN-Latin]
- EINECS 223-963-0
- Prestwick0_000148
- Prestwick1_000148
- Prestwick2_000148
- Prestwick3_000148
- BSPBio_000256
- CANRENOIC ACID [INN]
- SCHEMBL636758
- SPBio_002195
- BPBio1_000282
- CANRENOIC ACID [WHO-DD]
Look up CANRENOATE in the interactive SynDRA portal →